Research Article
The Clinical Features and Emotional Stressors in Korean Patients with Tako-Tsubo Cardiomyopathy
Table 4
The comparison of clinical courses and management between the subgroups.
| | Total (n = 103) | E group (n = 15) | Other group (n = 88) | P |
| Use of inotropics, n (%) | 28 (27) | 2 (13) | 26 (30) | 0.192 | Use of IABP, n (%) | 12 (12) | 0 (0) | 12 (14) | 0.128 | Use of ACEI or ARB, n (%) | 57 (55) | 10 (67) | 47 (53) | 0.340 | Use of beta blocker, n (%) | 21 (20) | 4 (27) | 17 (19) | 0.514 | Use of diuretic, n (%) | 40 (39) | 2 (13) | 38 (43) | 0.028* | Temporal pacemaker, n (%) | 10 (10) | 0 (0) | 10 (11) | 0.169 | Cardioversion, n (%) | 6 (6) | 0 (0) | 6 (7) | 0.297 | ICU hospitalization, n (%) | 63 (61) | 5 (33) | 58 (66) | 0.017* | ICU hospitalization (days)† | 2.0 (0–5.0) | 1.0 (0–2.0) | 3.0 (0–6.5) | 0.005* | Hospitalization (days)† | 14.0 (7.0–28.0) | 3.0 (3.0–9.0) | 17.0 (8.0–32.0) | 0.001* | In-hospital cardiac mortality, n (%) | 0 (0) | 0 (0) | 0 (0) | — | Cardiac mortality during followup, n (%) | 0 (0) | 0 (0) | 0 (0) | — | Mortality during followup, n (%) | 14 (14) | 0 (0) | 14 (16) | 0.097 | Recurrence, n (%) | 0 (0) | 0 (0) | 0 (0) | — |
|
|
IABP: intra-aortic balloon pump; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; ICU: intensive care unit. †Presented as median (inter-quartile range).
*Significant finding.
|